Tissue Heart Valve Market Analysis | Global | 2024-2030 | MedCore | Segmented by: Stented Tissue Heart Valves, Stentless Tissue Heart Valves, and 1 more

  • Year: 2024
  • Scope: 10 Years
  • Region: Global
  • Pages: 94
  • Published Date: 04/12/2024
  • Type: MedCore

Product Description

Overall, the global tissue heart valve market was valued at $1.55 billion in 2023. This is expected to increase over the forecast period at a CAGR of 0.1% to reach $1.56 billion.

The full report suite on the global market for tissue heart valve includes stented, stentless and sutureless tissue heart valves. Edwards Lifesciences, Medtronic, and Abbott were the top three market share leaders in the global tissue heart valve market.

MARKET DATA INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2030, and Historical Data to 2020
  • Recent Mergers & Acquisitions
  • Disease Overviews
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

GLOBAL TISSUE HEART VALVE MARKET INSIGHTS

Global Tissue Heart Valve Market

The market for tissue heart valves is increasingly being supported by the rise in popularity of sutureless and stentless models. These alternatives have demonstrated faster recovery times and fewer complications across various device models, as recent clinical evidence indicates. As such, the decline in the use of stented heart valves is a trend likely to persist throughout the forecast period, further driven by advancements in transcatheter aortic valve replacement (TAVR) and other minimally invasive procedures.

GLOBAL TISSUE HEART VALVE MARKET SHARE INSIGHTS

Global Tissue Heart Valve Market

Edwards Lifesciences leads the tissue heart valve market with its Carpentier-Edwards® surgical valves and PERIMOUNT® aortic products. Thanks to its global reach and established offerings, Edwards is poised to maintain its market dominance.

Medtronic, ranking second, offers Hancock™, Mosaic™, Avalus™, and other valves primarily used for aortic and mitral replacements. With its exit from the ventricular assist device sector, Medtronic is expected to enhance its footprint in the heart valve market.

Abbott, the third key player, provides the Epic™ mitral valve and Trifecta™ aortic valve. Despite a competitive market, Abbott is unlikely to increase its market share significantly in the coming period.

MARKET SEGMENTATION SUMMARY

Markets Included:

  • Stented Tissue Heart Valve Market
  • Stentless Tissue Heart Valve Market
  • Sutureless Tissue Heart Valve Market

Procedures Included:

  • Surgical Heart Valve Replacement – Segmented by:
    • Valve type: aortic, mitral, tricuspid, pulmonary

RESEARCH SCOPE SUMMARY

Report Attribute Details
Regions North America(Canada, United States)
Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam)
Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2023
Forecast 2024-2030
Historical Data 2020-2023
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

 

FREE Sample Report

 

Tissue heart valve Market
6.1 Executive Summary
6.1.1 Global Tissue Heart Valve Market Overview
6.1.2 Competitive Analysis
6.1.3 Procedures Included
6.1.4 Markets Included
6.1.5 Regions Included
6.2 Introduction
6.3 Procedure Numbers
6.3.1 Total Tissue Heart Valve Procedures
6.3.2 Aortic Tissue Heart Valve Procedures
6.3.3 Mitral Tissue Heart Valve Procedures
6.3.4 Tricuspid Tissue Heart Valve Procedures
6.3.5 Pulmonary Tissue Heart Valve Procedures
6.4 Market Overview
6.4.1 By Segment
6.4.2 By Region
6.5 Market Analysis and Forecast
6.5.1 Total Tissue Heart Valve Market
6.5.2 Stented Tissue Heart Valve Market
6.5.3 Stentless Tissue Heart Valve Market
6.5.4 Sutureless Tissue Heart Valve Market
6.6 Drivers and Limiters
6.6.1 Market Drivers
6.6.2 Market Limiters
6.7 Competitive Market Share Analysis
Edwards Lifesciences
Medtronic
Abbott
Corcym
Artivion
LifeNet Health
Others
Chart 6‑1: Tissue Heart Valve Market, Global, 2023 & 2030
Chart 6‑2: Tissue Heart Valve Procedures, Global, 2023
Chart 6‑3: Tissue Heart Valve Procedures by Segment, Global, 2020 – 2030
Chart 6‑4: Tissue Heart Valve Market by Segment, Global, 2020 – 2030
Chart 6‑5: Tissue Heart Valve Market by Region, Global, 2020 – 2030
Chart 6‑6: Leading Competitors, Tissue Heart Valve Market, Global, 2023
Figure 6‑1: Tissue Heart Valve Procedures Covered
Figure 6‑2: Tissue Heart Valve Markets Covered
Figure 6‑3: Tissue Heart Valve Regions Covered, Global (1 of 2)
Figure 6‑4: Tissue Heart Valve Regions Covered, Global (2 of 2)
Figure 6‑5: Tissue Heart Valve Procedures by Segment, Global, 2020 – 2030
Figure 6‑6: Tissue Heart Valve Procedures by Region, Global, 2020 – 2030
Figure 6‑7: Tissue Heart Valve Procedures by Country, North America, 2020 – 2030
Figure 6‑8: Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑9: Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑10: Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑11: Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑12: Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑13: Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030
Figure 6‑14: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑15: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑16: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑17: Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030
Figure 6‑18: Aortic Tissue Heart Valve Procedures by Region, Global, 2020 – 2030
Figure 6‑19: Aortic Tissue Heart Valve Procedures by Country, North America, 2020 – 2030
Figure 6‑20: Aortic Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑21: Aortic Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑22: Aortic Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑23: Aortic Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑24: Aortic Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑25: Aortic Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030
Figure 6‑26: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑27: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑28: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑29: Aortic Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030
Figure 6‑30: Mitral Tissue Heart Valve Procedures by Region, Global, 2020 – 2030
Figure 6‑31: Mitral Tissue Heart Valve Procedures by Country, North America, 2020 – 2030
Figure 6‑32: Mitral Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑33: Mitral Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑34: Mitral Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑35: Mitral Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑36: Mitral Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑37: Mitral Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030
Figure 6‑38: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑39: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑40: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑41: Mitral Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030
Figure 6‑42: Tricuspid Tissue Heart Valve Procedures by Region, Global, 2020 – 2030
Figure 6‑43: Tricuspid Tissue Heart Valve Procedures by Country, North America, 2020 – 2030
Figure 6‑44: Tricuspid Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑45: Tricuspid Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑46: Tricuspid Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑47: Tricuspid Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑48: Tricuspid Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑49: Tricuspid Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030
Figure 6‑50: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑51: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑52: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑53: Tricuspid Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030
Figure 6‑54: Pulmonary Tissue Heart Valve Procedures by Region, Global, 2020 – 2030
Figure 6‑55: Pulmonary Tissue Heart Valve Procedures by Country, North America, 2020 – 2030
Figure 6‑56: Pulmonary Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 6‑57: Pulmonary Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 6‑58: Pulmonary Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030
Figure 6‑59: Pulmonary Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 6‑60: Pulmonary Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 6‑61: Pulmonary Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030
Figure 6‑62: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 6‑63: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 6‑64: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 6‑65: Pulmonary Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030
Figure 6‑66: Tissue Heart Valve Market by Segment, Global, 2020 – 2030 (US$M)
Figure 6‑67: Tissue Heart Valve Market by Region, Global, 2020 – 2030 (US$M)
Figure 6‑68: Tissue Heart Valve Market, Global, 2020 – 2030
Figure 6‑69: Units Sold by Region, Tissue Heart Valve Market, Global, 2020 – 2030
Figure 6‑70: Average Selling Price by Region, Tissue Heart Valve Market, Global, 2020 – 2030 (US$)
Figure 6‑71: Market Value by Region, Tissue Heart Valve Market, Global, 2020 – 2030 (US$M)
Figure 6‑72: Stented Tissue Heart Valve Market, Global, 2020 – 2030
Figure 6‑73: Units Sold by Region, Stented Tissue Heart Valve Market, Global, 2020 – 2030
Figure 6‑74: Average Selling Price by Region, Stented Tissue Heart Valve Market, Global, 2020 – 2030 (US$)
Figure 6‑75: Market Value by Region, Stented Tissue Heart Valve Market, Global, 2020 – 2030 (US$M)
Figure 6‑76: Stentless Tissue Heart Valve Market, Global, 2020 – 2030
Figure 6‑77: Units Sold by Region, Stentless Tissue Heart Valve Market, Global, 2020 – 2030
Figure 6‑78: Average Selling Price by Region, Stentless Tissue Heart Valve Market, Global, 2020 – 2030 (US$)
Figure 6‑79: Market Value by Region, Stentless Tissue Heart Valve Market, Global, 2020 – 2030 (US$M)
Figure 6‑80: Sutureless Tissue Heart Valve Market, Global, 2020 – 2030
Figure 6‑81: Units Sold by Region, Sutureless Tissue Heart Valve Market, Global, 2020 – 2030
Figure 6‑82: Average Selling Price by Region, Sutureless Tissue Heart Valve Market, Global, 2020 – 2030 (US$)
Figure 6‑83: Market Value by Region, Sutureless Tissue Heart Valve Market, Global, 2020 – 2030 (US$M)
Figure 6‑84: Leading Competitors, Tissue Heart Valve Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

The global Heart Defects Closure Device Market Reportcontains analysis for Patent Foramen Ovale Closure Devices and Atrial & Ventricular Septal Defect Closure Devices. The global patent foramen ovale closure market and global atrial & ventricular septal defect closure markets are expected to reach $322.7M and $226.2M by 2027, respectively.

  • 2024
  • 10 Years
  • Global
  • MedCore
  • 04/12/2024
  • 94
SKU: iDATA_GLCS24_MC_THV Categories: , , ,
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library